Accession Number: | 0001645113-20-000040 |
Date: | 2020-03-03 |
Issuer: | NOVOCURE LTD (NVCR) |
Original Submission Date: |
GROENHUYSEN WILHELMUS CM
C/O NOVOCURE INC.,
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN, PA 19355
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
RESTRICTED SHARE UNITS | 2020-03-03 | A | 24,025 | a | $0.00 | 143,509 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTIONS TO BUY ORDINARY SHARES | 69.37 | 2020-03-03 | deemed execution date | A | 46,323 (a) | 2030-03-02 | ordinary shares 46,323 | $69.37 | 46,323 | direct |
ID | footnote |
---|---|
f1 | represents restricted share units that are scheduled to vest on march 3, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates. |
f2 | options to buy 46,323 ordinary shares will vest and become exercisable in equal installments on each of march 3, 2021, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates. |